Photo courtesy of Geninus
Geninus, a company specializing in genome analysis, announced on the 2nd that it signed a business agreement (MOU) with Kakao Healthcare for full-cycle health management for citizens.
Based on this MOU, both companies plan to promote domestic and overseas business of genomic diagnostic services, including direct-to-customer (DTC), and precision medical artificial intelligence (AI) platforms.
In addition, we plan to jointly carry out genome-related projects to generate and utilize genome data and manage the entire life cycle of citizens. We aim to provide all healthcare services needed by customers by promoting business development and joint promotions for DTC testing services.
In addition to its main business, single cell analysis and cancer genome analysis solutions, Geninus has experience securing 5,000 cases of Korean data through HealthSCAN, a health checkup genetic testing service for the general public, and has also commercialized DTC testing services. There is a bar.
Park Woong-yang, CEO of Geninus, said, “As the customized health care market based on personal genome analysis services is steadily expanding around the world, we are creating synergy through collaboration with Kakao Healthcare in line with the implementation of national customized service policies based on digital technology and big data. “Starting with this collaboration, we will develop our healthcare platform service and data business so that we can provide valuable services to our customers.”
Hwang Hee, CEO of Kakao Healthcare, said, “In order to provide hyper-personalized health management services through mobile healthcare, it is necessary to link with genomic information in addition to clinical information and lifestyle information.” He added, “Geninus and Geninus, which already have diverse experience at home and abroad, “I look forward to collaborating.”
Source: Pangyo Techno Valley Official Newsroom
→ Go to ‘Asia Innovation Hub Pangyo Techno Valley 2022’ news